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PhosphotungestateAbstract Oseltamivir phosphate (OP) is an antiviral drug that is used in the treatment and prophy-
laxis of both inﬂuenza A and inﬂuenza B. It is effective against all known inﬂuenza viruses that can
infect humans, including pandemic inﬂuenza viruses and may be the most appropriate antiviral
option against avian inﬂuenza caused by H5N1 virus. Tamiﬂu, the registered trademark used under
exclusive license by Roche laboratories with OP as active pharmaceutical ingredient, is considered
the best treatment for the bird ﬂu disease.
The construction and electrochemical response characteristics of poly vinyl chloride (PVC) mem-
brane sensors for the determination of (OP) were described. The sensors are based on the use of the
ion association complexes of (OP) cation with sodium tetraphenylborate–oseltamivir phosphate
(NaTPB–OP), tungestosilisate–oseltamivir phosphate (TS–OP), phosphomolbdate–oseltamivir
phosphate (PM–OP) and phosphotungestate–oseltamivir phosphate (PT–OP) as ion exchange sites
in the PVC matrix. The performance characteristics of these sensors, which were evaluated accord-
ing to IUPAC recommendations, reveal a fast, stable and linear response for (OP) over the concen-
tration range from 105 to 102 mol L1 with cationic slopes of 51.5 ± 0.3, 50 ± 0.5, 55 ± 0.2 and
50 ± 0.4 mV per decade across an extended OP concentration range from 1.0 · 106 to 1.0 ·
102 mol L1 for NaTPB–OP, TS–OP, PM–OP and PT–OP, respectively. The direct potentiometric
determination of (OP) using the proposed sensors gave average recoveries of 99.9, 99.8, 99.9 and
99.7 for NaTPB–OP, TS–OP, PM–OP and PT–OP, respectively. The sensors are used for determi-
nation of (OP) in tablets. The method was successfully applied to commercial pharmaceuticals,
Tamiﬂu. Validation of the method shows suitability of the proposed sensors for use in the quality
A new ion selective electrode method for determination of oseltamivir phosphate (Tamiﬂu) S237control assessment of (OP). The developed method was found to be simple, accurate and precise
when compared with a reported HPLC method.
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Oseltamivir is an antiviral drug that slows the spread of inﬂu-
enza (ﬂu) virus between cells in the body by stopping the virus
from chemically cutting ties with its host cell––median time to
symptom alleviation is reduced by 0.5–1 day. The drug is sold
under the trade name Tamiﬂu and is taken orally in capsules or
as a suspension. It has been used to treat and prevent inﬂuenza
virus A and inﬂuenza virus B. Systematic (IUPAC) name:
Ethyl (3R, 4R, 5S)-5-amino-4-acetamido-3- (pentan-3-yloxy)
cyclohex-1-ene-1-carboxylate phosphoric acid and the struc-
ture is: C16H31N2O8P (Burch et al., 2009).
Oseltamivir is administered by oral inhalation for the treat-
ment of inﬂuenza infection. It is a neuraminidase inhibitor.
When started within 36 h of symptom onset, oseltamivir can
decrease the severity and duration of symptoms caused by
either inﬂuenza A or B (Mondel, 2008). The antiviral drug
oseltamivir (Tamiﬂu) has received recent attention due to the
potential use as a ﬁrst-line defense against H5N1 and H1N1
inﬂuenza viruses. Oseltamivir is not removed during conven-
tional wastewater treatments, thus having the potential to en-
ter surface water bodies (Accinelli et al., 2010). Oseltamivir is it
not virally effective; however, once in the liver, it is converted
by natural chemical processes, hydrolyzed hepatically to its
active metabolite, the free carboxylate of OP.
OP is a neuraminidase inhibitor, serving as a competitive
inhibitor toward sialic acid, found on the surface proteins of
normal host cells. By blocking the activity of the viral neur-
aminidase enzyme, oseltamivir prevents new viral particles
from being released by infected cells (R. Laboratories, 2008).
The most common side effects are mild to moderate nausea
and vomiting ( Rossi, 2006). Clinical practices showed that
oseltamivir was effective to treat the 2009-H1N1 inﬂuenza
but failed to the 2006-H5N1 avian inﬂuenza (Wang et al.,
2009). A number of studies have been reported for the determi-
nation of OP by chromatographic methods (Lindega˚rdh et al.,
2007; Fuke et al., 2008; Charles et al., 2007; Lindegardh et al.,
2008, 2006; Bahrami et al., 2008; Yamazaki et al., 2008; Heinig
and Bucheli, 2008). OP has been predicted to reach high con-
centrations in surface waters and sewage works (Straub, 2009;
Bartels and Tu¨mpling, 2008). OP is the ﬁrst orally adminis-
tered neuraminidase (NA) inhibitor approved for use in treat-
ment and prevention of inﬂuenza virus infection in man (Carr
et al., 2002). OP resistance among inﬂuenza A (H1N1) viruses
rapidly emerged and spread globally during the 2007–2008 and2008–2009 inﬂuenza seasons (Adhiambo et al., 2010). Several
neuraminidase (NA) assays are available for the evaluation
of neuraminidase inhibitors (NAIs) (Su et al., 2008). Electro-
phoresis method was developed and validated for the assay
of OP in capsules (Kummer et al., 2009). We present a sensitive
and speciﬁc approach for detection of pandemic inﬂuenza A/
H1N1 2009 and a rapid RT-PCR assay detecting a primary
oseltamivir resistance mutation which can be incorporated eas-
ily into clinical virology algorithms (Vries et al., 2010). OP is
converted in the human body into the pharmacologically
active metabolite, oseltamivir acid, with a yield of 75%. Osel-
tamivir acid is indirectly photodegradable and slowly biode-
gradable in sewage works and sediment/water systems
(Escher et al., 2010). There are many conserved residues in
the Neuraminidase (NA) active site that are involved in NA
inhibitor binding; only a few have been demonstrated to confer
resistance (Ho et al., 2007). A resin linked with the Tamiﬂu
core was synthesized by modifying our original synthetic route
of OP (Kimura et al., 2009). Oseltamivir Carboxylate (OC),
the active metabolite of the prod rug (OP), has the potential
to be released into water bodies (Sacca` et al., 2009). The neur-
aminidase inhibitors (NAIs) are an effective class of antiviral
drugs for the treatment of inﬂuenza A and B infections. Until
recently, only a low prevalence of NAI resistance (<1%) had
been detected in circulating viruses (Hurt et al., 2009). In this
work the determination of OP was done by the ion-selective
electrode method, some Voltammetric and Electroanalytical
methods were used in the literature (Gupta et al., 2006, 2008,
2010a,b, 2011a,b, 1997; Singh et al., 2007; Srivastava et al.,
1995; Jain et al., 1995a,b, 2005, 1997; Srivastava et al., 1996;
Prasad et al., 2004; Gupta and Kumar, 1999; Goyal et al.,
2009a,b, 2008, 2007a,b,c, 2005a,b; Goal et al., 2008; Bachheti
et al., 2006; Goyal and Gupta, 2011a; Goyal and Gupta,
2011b; Gupta, 2011; Dwivedi et al., 2011; Gupta and Jain,
2010).
2. Experimental
2.1. Apparatus
All Potentiometric measurements were made at 25 ± 1 C
with an Orion (Model 720) pH/mV meter. Double junction
Ag/AgCl reference electrode was used. An Orion electrode
(Model 90–02) ﬁlled with 10% (w/v) potassium chloride was
used in the outer compartment. Combination glass (Ross
pH) electrode (Orion Model 81–02) was used for all pH
measurements.
2.2. Reagents and materials
All chemicals were of analytical reagent grade unless otherwise
stated and doubly distilled water was used throughout. Osel-
tamivir Phosphate (OP), Poly (vinyl chloride) powder (PVC),
Tetrahydrofuran, butylatedhydroxytoluene, and o-Nitrophe-
Calibration curve
0
50
100
150
200
250
300
350
6 5 4 3 2
-Log [OP]
-
E(
mV
) NaTPB
TS
PM
PT
Figure 1 Calibration curves and the optimum responses of the
NaTPB–OP, TS–OP, PM–OP and PT–OP sensors.
S238 S.M. Hamza et al.nyloctylether (o-NPOE), were obtained from Aldrich Chem.
Co. (Milwaukee, WI, USA. OP (102 M) stock solution was
prepared by dissolving 0.1025 g of OP in 25 ml of (0.05 M)
phosphate buffer solution (pH 7). OP (102–106 M) standard
solutions were prepared by appropriate dilution of the stock
OP solution with 0.05 M phosphate buffer solution of pH 7.
The following cations and compound solutions were pre-
pared and standardized using the standard methods. Dilute
solutions (102–106 mol L1) of these cations and com-
pounds were prepared by a 10-fold dilution of the stock solu-
tions with 0.05 M phosphate buffer solution of pH 7. Sodium
tetraphenylborate (NaTPB), tungestosilisate (TS), phospho-
molbdate (PM) and phosphotungestate (PT) as ion-exchangers
ion pair (electroactive material) were used.
2.3. Preparation ofNaTPB–OP, TS–OP, PM–OP and PT–OP,
the ion exchangers
The ion exchangers, (NaTPB–OP), (TS–OP), (PM–OP) and
(PT–OP) were prepared by mixing 25 ml of 1.0 · 102 mol L1
OP with 20 ml of 1.0 · 102 mol L1 NaTPB, TS, PM and PT,
respectively. The white, the white, the yellow and the yellowish
white, respectively, precipitates formed, after digestion over-
night, were ﬁltered, and washed by double distilled water until
dried at room temperature.
2.4. Electrodes preparation
Master PVC membrane of approximately 0.1 mm thick was
optimized and prepared as described elsewhere (Elsaid et al.,
2010). By mixing a 10 mg (NaTPB–OP), (TS–OP), (PM–OP)
and (PT–OP) based ion pair complexes with 200 mg of o-
NPOE plasticizer, 100 mg of PVC matrix, and 6 mL THF.
The viscous solution thus obtained was poured in a glass Petri
dish (5 cm diameter) and the solvent was allowed to evaporate
for about 24 h at room temperature. The master PVC mem-
branes were sectioned with a cork borer (8 mm diameter)
and attached to a polyethylene tubing (3 cm length and
5 mm i.d.) using THF. A home made electrodes body was used
which consists of a glass tube, to one end of which the polyeth-
ylene tubing was tightly inserted and ﬁlled with an equimolar
mixture of 102 mol L1 KCl and OP as an internal reference
solution. An Ag/AgCl internal reference wire electrode was im-
mersed in the internal reference solution. This assembly was
used as a sensitive electrode in the potentiometric measure-
ments of OP. The electrode was conditioned by soaking in
102 mol L1 OP solution for 4 h before use and stored in
the same solution when not in use.
2.5. Analytical characterization of OP electrodes
The proposed electrode was calibrated by measuring the emf
values after stabilization to±0.5 mV in a series of OP solutions
covering the concentration range from 1.0 · 106 to
1.0 · 102 mol L1 OP. The emf values were plotted on a semi
logarithmic paper as a function of OP concentration. The ob-
tained calibration curve was used for subsequent determination
of the unknown OP samples. The selectivity coefﬁcients for for-
eign ions were determined by the separate solution method
(SSM) Umezaw et al., 2000 in which the potential readings
(mV) of the two separate solutions one containing only theOP ion at the concentration level of 103 mol L1 and the other
containing the interferent ions at the same concentration level
were measured. The selectivity coefﬁcients KPotOP were calculated
using the experimentally obtained slope. The response time (t
95%) of the proposed electrode was also, tested by measuring
the time required to achieve a 95% steady potential for the test
solutions, when the OP ion concentration was rapidly increased
by one decade from 1.0 · 106 to 1.0 · 102 mol L1. The po-
tential readings were recorded against time (sec). The lifetime
of the investigated OP electrodes was measured from the re-
sponse potential to the varying OP concentration 2 days a week
for more than one month.
3. Results and discussion
3.1. The Calibration curve and statistical data
The optimum responses of the NaTPB–OP, TS–OP, PM–OP
and PT–OP sensors were evaluated, after conditioning the
membranes with the same composition for different time peri-
ods in a 1.0 · 102 mol L1 OP solution. The slope, obtained
after a 12 h conditioning, was closer to the theoretically
expected slopes, considering the Nernstian equation as a basis.
Longer conditioning times produced no further improvement
in the response. The optimum conditioning solution was found
to have a concentration of about 102 mol L1 for four mem-
branes. The critical response characteristics of the recom-
mended sensor were assessed according to the IUPAC
recommendations (IUPAC, 1976). The emf response of the
polymeric membrane indicated Nernstian slopes of 51.5 ±
0.3 mV, 50 ± 0.5, 55 ± 0.2 and 50 ± 0.4 per decade across
an extended OP concentration range from 1.0 · 106 to
1.0 · 102 mol L1 for NaTPB–OP, TS–OP, PM–OP and
PT–OP, respectively. The detection limits, deﬁned as OP con-
centration obtained when extrapolating the linear region of the
calibration graph to the base line potential, were 1.5 · 105 to
1.0 · 102 mol L1, 2.0 · 105 to 1.0 · 102 mol L1, 2.5 ·
105 to1.0 · 102 mol L1, 3.5 · 105 to 1.0 · 102 mol L1,
respectively. The results observed are presented in Fig. 1.
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Figure 2 Effect of pH of the test solution on the potential
reading: 1.0 · 104 and 1.0 · 103 mol L1 OP solution at 25 C
using NaTPB–OP electrode.
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Figure 3 Effect of pH of the test solution on the potential
reading: 1.0 · 104 and 1.0 · 103 mol L1 OP solution at 25 C
using TS–OP electrode.
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Figure 4 Effect of pH of the test solution on the potential
reading: 1.0 · 104 and 1.0 · 103 mol L1 OP solution at 25 C
using PT–OP electrode.
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Figure 5 Effect of pH of the test solution on the potential
reading: 1.0 · 104 and 1.0 · 103 mol L1 OP solution at 25 C
using PM–OP electrode.
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Figure 6 The response time of the membranes NaTPB–OP, TS–
OP, PM–OP and PT–OP sensors, A = 106, B = 105, C = 104,
D = 103, and E = 102 mol L1.
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electrodes
The inﬂuences of the pH of a test solution on the proposed OP
electrodes potentiometric response were studied at two OP
concentrations (1.0 · 103 and 1.0 · 104 mol L1), where the
pH was adjusted from 1 to 10 with H3PO4 or NaOH solutions.
The results observed are presented in Figs. 2–5.
As it can be seen, the potential is independent on the pH
changes in the range of 5–8. Thus, this range may be chosen
as the working pH for the electrodes assembly. At pH < 5,
the OP cation was protonated, whereas, at relatively high pH
the potential decreases more signiﬁcantly probably due to
membrane response to OH. The observed potential changes
at the lower and higher pH values could be caused by the
Table 1 Potentiometric selectivity coefﬁcients (KPotOP ) for the four proposed electrodes (NaTPB–OP, TS–OP, PM–OP and PT–OP).
Interferents NaTPB–OP TS–OP PM–OP PT–OP
p-Nitroanaline (pNA) 1.1 · 101 6.5 · 102 6.0 · 103 5.2 · 102
Nicotine amide (NA) 3.2 · 101 4.6 · 102 9.2 · 103 7.6 · 102
Ammonium oxalate (AO) 5.8 · 102 5.1 · 101 1.4 · 102 7.5 · 102
Ammonium citrate (AC) 3.2 · 101 8.5 · 101 3.9 · 102 2.4 · 101
L-Alinine (L-al) 1.6 · 101 1.4 · 101 2.4 · 102 9.2 · 102
Semicarbazide (SC) 8.5 · 101 8.5 · 101 1.9 · 101 3.5 · 101
Glutamine (GLU) 3.2 · 101 8.5 · 101 9.2 · 102 5.8 · 101
Nicotine (Nic) 3.2 · 101 1.3 · 101 1.3 · 102 9.0 · 102
Sodium salicylate (SS) 1.4 · 103 4.6 · 103 6.0 · 103 1.6 · 102
Sodium benzoate (SB) 5.8 · 101 1.5 · 102 1.2 · 102 3.5 · 102
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Figure 7 The response of NaTPB electrode against OP and some
cations.
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Figure 8 The response of TS electrode against OP and some
cations.
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Figure 9 The response of PM electrode against OP and some
cations.
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Figure 10 The response of PT electrode against OP and some
cations.
S240 S.M. Hamza et al.ion carrier protonation as well as the formation of some
hydroxyl complexes of OP ion in the solution.
Table 2 Response characteristics for NaTPB–OP, TS–OP, PM–OP and PT–OP membranes.
Parameters NaTPB–OP TS–OP PM–OP PT–OP
Slope (mV/decade) 51.5 ± 0.3 50 ± 0.5 55 ± 0.2 50 ± 0.4
Intercept (mV) 294 310 260 284
Correlation coeﬃcient 0.9998 0.9999 0.9997 0.99996
Detection limit (M) 1.5 · 105 2.0 · 105 2.5 · 105 3.5 · 105
Quantiﬁcation limit (M) 1.0 · 105 1.5 · 105 2.0 · 105 2.5 · 105
Response time (s) 30 30 30 30
Working pH range 5–8 5–8 5–8 5–8
Concentration range (M) mol L1 1.5 · 105 to 1.0 · 102 2.0 · 105 to 1.0 · 102 2.5 · 105 to 1.0 · 102 3.5 · 105 to 1.0 · 102
Life span (days) 25 20 20 25
Average recovery a (%) 99.9 99.8 99.9 99.7
a Average of four determinations.
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For analytical applications, the dynamic response time gener-
ally consists of a considerable parameter for any sensor
(Matysik et al., 1998). The dynamic response time for the
OP electrode from lower concentrations (1.0 · 106 mol L1)
to higher concentrations (1.0 · 102 mol L1) was recorded.
The actual potential versus time tracer is presented in Fig. 6.
The dynamic response time of the membranes was mea-
sured at various concentrations (1.0 · 106 to 1.0 · 102
mol L1) of the test solutions. The reported results in Fig. 6
illustrate that in the whole concentration range the electrodes
reach its equilibrium response very fast (10 s). As it can be
seen, the proposed OP electrodes provide fast response time
(<30 s.) to reach 95% of its ﬁnal steady state potential in
the tested concentration range. The electrodes lifetime was also
measured by employing one of the electrodes for a 6-week per-
iod. In this period, the electrodes were used for 1 h each day
and, then, washed and dried. The lifetime measured in this
way was found to be two weeks to1 month, during which the
electrodes slope displayed only a slight change from 50 to
55 mV per decade.
3.4. Selectivity coefﬁcient of OP
Selectivity is an important characteristic, which deﬁnes the nat-
ure of the device and the range to which it may be successfully
employed. The selectivity of the ion selective electrodes under
consideration was also, investigated with respect to some com-
mon cations using SSM. The selectivity coefﬁcients of the pro-
posed membrane selective electrode were determined against a
number of different cations by using SSM. The data obtained,
showed that the selectivity coefﬁcient (KPotOP ) values ranging
from 5.8 · 102 to 8.5 · 101, 4.6 · 103 to 8.5 · 101,
6.0 · 103 to 1.99 · 101, 1.6 · 102 to 5.8 · 101 for NaT-
PB–OP, TS–OP, PM–OP and PT–OP respectively, for the
tested cations. These values clearly indicate that, the proposed
electrodes were fairly selective to OP cation over different
tested cations. Nevertheless, for all of the diverse ions used,
the selectivity coefﬁcients were lower than 8.5 · 101,
8.5 · 101, 1.99 · 101, and 5.8 · 101 for NaTPB–OP, TS–
OP, PM–OP and PT–OP, respectively, indicating that the stud-
ied common cations would not signiﬁcantly disturb the deter-
mination of OP according to the SSM, the potentiometric
selectivity coefﬁcients were determined using 1 · 103 mol L1test solution of different cations at pH = 5–8. The resulting
selectivity coefﬁcients are summarized in Table 1.
The selectivity coefﬁcient is an important measure on the
selectivity of an ion. For the determination of selectivity coef-
ﬁcients mixed solution method was preferred as it usually cor-
responds more closely to the situation in the sample. For this
purpose solutions were prepared with a constant activity of the
main ion (102 mol L1OP) and varying activity of interfering
ion (102 to 105). The change of potential for each addition of
interfering ion is recorded. The potentials obtained at different
concentrations of OP and interfering ions are plotted against
concentrations as shown in Figs. 7–10. In these work possible
interferences of p-Nitroanaline (pNA), Nicotine Amide (NA),
Ammonium Oxalate (AO), Ammonium Citrate (AC) L-Alinine
(L-al), Semicarbazide (SC), Glutamine (GLU), Nicotine (Nic),
Sodium Salicylate (SS), and Sodium Benzoate (SB) were stud-
ied. Selectivity coefﬁcients (kpotA;B) were calculated using the
equation given below (Srinivasan and Rechnitz, 1969).
kpotA;B ¼ antilogE1 E2=S where, S= 2.303 RT/nF (the slope
of OP electrodes), E1 the potential measured when only A is
present, E2 the potential responsive to the primary ion in the
presence of interfering ion, kA,B the selectivity coefﬁcient.
The results are summarized in Table 1 and as can be observed
from Figs. 7–10. No signiﬁcant interference is caused by the
examined ions except semicarbazide (Sc) that explain the
monovalent of OP (n= 1) response due to –NH group which
connected with CO and no effect of –NH2 group (free amino
group).
3.5. OP electrodes response characteristics
The proposed (NaTPB–OP), (TS–OP), (PM–OP)and
(PT–OP)-based ion pair complexes were prepared, identiﬁed
and examined as electroactive sensing material in PVC mem-
brane based electrode responsive for OP cation. The electro-
chemical performance characteristics of the electrodes were
systematically evaluated according to IUPAC recommenda-
tions (Buck and Lindner, 1994), and the results obtained are
given in Table 2.
4. Analytical applications
In order to test the analytical validity of this approach, the
method has been applied for the determination of OP in phar-
maceutical preparations by direct potentiometry using the
Table 3 Determination of salicylate in different OP tablet samples (n= 10): Comparison of potentiometric results with an
independent HLPC method.
OP samples mg/tablet NaTPB–OP TS–OP PM–OP PT–OP HLPC
75 70 ± 0.5 72 ± 0.6 71 ± 0.8 70 ± 0.6 74 ± 0.5
150 142 ± 0.4 144 ± 0.2 140 ± 0.6 143 ± 0.5 145 ± 0.4
S242 S.M. Hamza et al.calibration graph and standard additions technique (HPLC
method) Charles et al., 2007. Tamiﬂu, the registered trademark
used under exclusive license by Roche laboratories (Swiss
made) with OP as active pharmaceutical ingredient, is consid-
ered the best drug for treatment of the bird ﬂu disease, one
Tamiﬂu capsule containing 75 mg of OP.
The high degree of OP selectivity exhibited by the electrodes
based on the NaTPB–OP, TS–OP, PM–OP and PT–OP makes
it potentially useful for monitoring concentration levels of OP
in real samples. To assess the applicability of the membrane
electrodes in real samples, an attempt was made to determine
OP in pharmaceutical preparations. The proposed electrodes
were applied to determine OP in pharmaceutical samples using
the standard addition method. The solutions were prepared by
the method described in reagents and materials and were ﬁl-
tered if necessary. The results are presented in Table 3 and indi-
cate good agreement between the potentiometric and HPLC
method.
5. Conclusion
In the present study, we report our observation of new four
constructed sensors for OP detection over a wide range of con-
centrations from 1.0 · 105 to 102 mol L1. Three are based
on the use of NaTPB–OP, TS–OP, PM–OP and PT–OP, ion
pair complexes as electroactive compounds dispersed in plasti-
cized poly (vinyl chloride). The fourth sensor is based on plas-
ticized o-NPOE, PVC without ion pair complex. The
concentration levels of OP are in the range of these in pharma-
ceuticals and this is an important consideration. We have devel-
oped quicker and more feasible methodologies of analysis
based on novel sensors with high selectivity and sensitivity
and are very reproducible; they also displayed faster response
time, high stability, and suitable life time, low cost and simple
design.
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